BACKGROUND AND OBJECTIVES: The prevalence of ESRD among Hispanics/Latinos is 2-fold higher than in non-Hispanic whites. However, little is known about the prevalence of earlier stages of CKD among Hispanics/Latinos. This study estimated the prevalence of CKD in US Hispanics/Latinos. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a cross-sectional study of 15,161 US Hispanic/Latino adults of Cuban, Dominican, Mexican, Puerto Rican, Central American, and South American backgrounds enrolled in the multicenter, prospective, population-based Hispanic Community Health Study/Study of Latinos (HCHS/SOL). In addition, the prevalence of CKD in Hispanics/Latinos was compared with other racial/ethnic groups in the 2007-2010 National Health and Nutrition Examination Survey (NHANES). Prevalent CKD was defined as an eGFR <60 ml/min per 1.73 m(2) (estimated with the 2012 Chronic Kidney Disease Epidemiology Collaboration eGFR creatinine-cystatin C equation) or albuminuria based on sex-specific cut points determined at a single point in time. RESULTS: The overall prevalence of CKD among Hispanics/Latinos was 13.7%. Among women, the prevalence of CKD was 13.0%, and it was lowest in persons with South American background (7.4%) and highest (16.6%) in persons with Puerto Rican background. In men, the prevalence of CKD was 15.3%, and it was lowest (11.2%) in persons with South American background and highest in those who identified their Hispanic background as "other" (16.0%). The overall prevalence of CKD was similar in HCHS/SOL compared with non-Hispanic whites in NHANES. However, prevalence was higher in HCHS/SOL men and lower in HCHS/SOL women versus NHANES non-Hispanic whites. Low income, diabetes mellitus, hypertension, and cardiovascular disease were each significantly associated with higher risk of CKD. CONCLUSIONS: Among US Hispanic/Latino adults, there was significant variation in CKD prevalence among Hispanic/Latino background groups, and CKD was associated with established cardiovascular risk factors.
BACKGROUND AND OBJECTIVES: The prevalence of ESRD among Hispanics/Latinos is 2-fold higher than in non-Hispanic whites. However, little is known about the prevalence of earlier stages of CKD among Hispanics/Latinos. This study estimated the prevalence of CKD in US Hispanics/Latinos. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a cross-sectional study of 15,161 US Hispanic/Latino adults of Cuban, Dominican, Mexican, Puerto Rican, Central American, and South American backgrounds enrolled in the multicenter, prospective, population-based Hispanic Community Health Study/Study of Latinos (HCHS/SOL). In addition, the prevalence of CKD in Hispanics/Latinos was compared with other racial/ethnic groups in the 2007-2010 National Health and Nutrition Examination Survey (NHANES). Prevalent CKD was defined as an eGFR <60 ml/min per 1.73 m(2) (estimated with the 2012 Chronic Kidney Disease Epidemiology Collaboration eGFRcreatinine-cystatin C equation) or albuminuria based on sex-specific cut points determined at a single point in time. RESULTS: The overall prevalence of CKD among Hispanics/Latinos was 13.7%. Among women, the prevalence of CKD was 13.0%, and it was lowest in persons with South American background (7.4%) and highest (16.6%) in persons with Puerto Rican background. In men, the prevalence of CKD was 15.3%, and it was lowest (11.2%) in persons with South American background and highest in those who identified their Hispanic background as "other" (16.0%). The overall prevalence of CKD was similar in HCHS/SOL compared with non-Hispanic whites in NHANES. However, prevalence was higher in HCHS/SOL men and lower in HCHS/SOL women versus NHANES non-Hispanic whites. Low income, diabetes mellitus, hypertension, and cardiovascular disease were each significantly associated with higher risk of CKD. CONCLUSIONS: Among US Hispanic/Latino adults, there was significant variation in CKD prevalence among Hispanic/Latino background groups, and CKD was associated with established cardiovascular risk factors.
Authors: Ana C Ricardo; Cheryl A Anderson; Wei Yang; Xiaoming Zhang; Michael J Fischer; Laura M Dember; Jeffrey C Fink; Anne Frydrych; Nancy G Jensvold; Eva Lustigova; Lisa C Nessel; Anna C Porter; Mahboob Rahman; Julie A Wright Nunes; Martha L Daviglus; James P Lash Journal: Am J Kidney Dis Date: 2014-11-20 Impact factor: 8.860
Authors: T H Jafar; C H Schmid; M Landa; I Giatras; R Toto; G Remuzzi; G Maschio; B M Brenner; A Kamper; P Zucchelli; G Becker; A Himmelmann; K Bannister; P Landais; S Shahinfar; P E de Jong; D de Zeeuw; J Lau; A S Levey Journal: Ann Intern Med Date: 2001-07-17 Impact factor: 25.391
Authors: Rudolph A Rodriguez; German T Hernandez; Ann M O'Hare; David V Glidden; Eliseo J Pérez-Stable Journal: Kidney Int Date: 2004-12 Impact factor: 10.612
Authors: Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Priya Vart; Ron T Gansevoort; Josef Coresh; Sijmen A Reijneveld; Ute Bültmann Journal: Clin J Am Soc Nephrol Date: 2013-06-27 Impact factor: 8.237
Authors: Chaoyang Li; Xiao-Jun Wen; Meda E Pavkov; Guixiang Zhao; Lina S Balluz; Earl S Ford; Desmond Williams; Carol A Gotway Journal: Am J Nephrol Date: 2014-04-12 Impact factor: 3.754
Authors: Martha L Daviglus; Gregory A Talavera; M Larissa Avilés-Santa; Matthew Allison; Jianwen Cai; Michael H Criqui; Marc Gellman; Aida L Giachello; Natalia Gouskova; Robert C Kaplan; Lisa LaVange; Frank Penedo; Krista Perreira; Amber Pirzada; Neil Schneiderman; Sylvia Wassertheil-Smoller; Paul D Sorlie; Jeremiah Stamler Journal: JAMA Date: 2012-11-07 Impact factor: 56.272
Authors: Ana C Ricardo; Matthew Shane Loop; Franklyn Gonzalez; Claudia M Lora; Jinsong Chen; Nora Franceschini; Holly J Kramer; Stephanie M Toth-Manikowski; Gregory A Talavera; Martha Daviglus; James P Lash Journal: J Am Soc Nephrol Date: 2020-04-16 Impact factor: 10.121
Authors: David B Hanna; Shuo Xu; Michal L Melamed; Franklyn Gonzalez; Matthew A Allison; Martin S Bilsker; Barry E Hurwitz; Mayank M Kansal; Neil Schneiderman; Sanjiv J Shah; Robert C Kaplan; Carlos J Rodriguez; Jorge R Kizer Journal: Am J Cardiol Date: 2017-03-29 Impact factor: 2.778
Authors: James P Lash; Ana C Ricardo; Jason Roy; Rajat Deo; Michael Fischer; John Flack; Jiang He; Martin Keane; Claudia Lora; Akinlolu Ojo; Mahboob Rahman; Susan Steigerwalt; Kaixiang Tao; Myles Wolf; Jackson T Wright; Alan S Go Journal: Am J Kidney Dis Date: 2016-05-19 Impact factor: 8.860
Authors: M Larissa Avilés-Santa; Neil Schneiderman; Peter J Savage; Robert C Kaplan; Yanping Teng; Cynthia M Pérez; Erick L Suárez; Jianwen Cai; Aida L Giachello; Gregory A Talavera; Catherine C Cowie Journal: Endocr Pract Date: 2016-06-13 Impact factor: 3.443
Authors: Esteban A Cedillo-Couvert; Jesse Y Hsu; Ana C Ricardo; Michael J Fischer; Ben S Gerber; Edward J Horwitz; John W Kusek; Eva Lustigova; Amada Renteria; Sylvia E Rosas; Milda Saunders; Daohang Sha; Anne Slaven; James P Lash Journal: Clin J Am Soc Nephrol Date: 2018-10-18 Impact factor: 8.237